Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cunningham

Showing results (751-760 of 1,101) with videos related to

Pageof 111
Sort By:
Oncology|December 15, 2010
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancerA F C Okines, U Asghar, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Unknown primary carcinoma: randomised studies are needed to identify optimal treatments and their benefitsD C Farrugia, A R Norman, M C Nicolson, et al.
Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.
British Journal of Cancer|October 1, 1993
The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphomaT Hickish, D Cunningham, K Colston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancerM Findlay, A Hill, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphomaM Hill, D Cunningham, D MacVicar, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug schedulingJ Mansi, E Ellis, C Viner, et al.
The British Journal of Radiology|September 3, 2013
The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasisH H Tam, D J Collins, G Brown, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488)D Cunningham, M Soukop, J F Stuart, et al.
Seminars in Oncology|March 1, 1985
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer GroupS Banham, A Dorward, A Hutcheon, et al.
Pageof 111

Showing results (751-760 of 1,101) with videos related to

Sort By:
Pageof 111
Oncology|December 15, 2010
Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancerA F C Okines, U Asghar, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1996
Unknown primary carcinoma: randomised studies are needed to identify optimal treatments and their benefitsD C Farrugia, A R Norman, M C Nicolson, et al.
Lancet (London, England)|April 19, 1997
BCL-2 antisense therapy in patients with non-Hodgkin lymphomaA Webb, D Cunningham, F Cotter, et al.
British Journal of Cancer|October 1, 1993
The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphomaT Hickish, D Cunningham, K Colston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancerM Findlay, A Hill, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphomaM Hill, D Cunningham, D MacVicar, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug schedulingJ Mansi, E Ellis, C Viner, et al.
The British Journal of Radiology|September 3, 2013
The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasisH H Tam, D J Collins, G Brown, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488)D Cunningham, M Soukop, J F Stuart, et al.
Seminars in Oncology|March 1, 1985
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer GroupS Banham, A Dorward, A Hutcheon, et al.
Pageof 111